Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joanna Ciepła
Observed name:
Ciepła, Joanna
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0009-0006-5325-2369
Observed ORCID:
0009-0006-5325-2369
OpenAlex ID:
A5099012029
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
2024
·
Joanna Ciepła
, Ryszard Smolarczyk
·
Clinical and Experimental Medicine
·
92
PDF
Combination of STING agonist with anti-vascular RGD-(KLAKLAK)2 peptide as a novel anti-tumor therapy
2024
·
Justyna Czapla
, Alina Drzyzga
, et al.
·
Cancer Immunology Immunotherapy
·
14
Comparison of Micelles Single- and Dual-Targeted with Folic Acid and Biotin as the Delivery System of Docetaxel─The Influence of the Type and Amount of the Ligand on Morphology, Physicochemical Properties, and Cytotoxicity
2025
·
Magdalena Jurczyk
, Ryszard Smolarczyk
, et al.
·
Molecular Pharmaceutics
·
4
TLR7 Agonist Imiquimod Improves the Therapeutic Antitumor Effect of High–Dose–Rate Brachytherapy
2026
·
Magdalena Jarosz-Biej
, Ryszard Smolarczyk
, et al.
·
Cancers
·
2
PDF
Minimizing systemic toxicity of doxorubicin via targeted delivery of hypoxia-sensitive polymersomes
2026
·
Joanna Ciepła
, Katarzyna Jelonek
, et al.
·
Nanomedicine Nanotechnology Biology and Medicine
·
2
Correction: Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
2025
·
Magdalena Jarosz-Biej
, Justyna Czapla
, et al.
·
Cancer Immunology Immunotherapy
·
2
PDF
Targeting STING Signalling Polarizes Tumor-Associated Neutrophils to Boost Anticancer and Abscopal Antimetastatic Functions
2026
·
Alina Drzyzga
, Justyna Czapla
, et al.
·
ImmunoTargets and Therapy
Show more works
View as search
Works count:
8
Citation count:
116
H-index:
3
I10-index:
2
Year
Topic
Type